Scientific Studies

cropped-Ultimo-logo-Copia.jpgDear reader, we hope that this list of publications about cannabinoids and the pharmacological effects of CBD and other cannabinoids, can help you understand the real potential of this new chemical entity. Pharmotech SA is constantly striving to keep its expertise and information up-to-date and will simultaneously inform on this platform our readers on the most important discoveries on the CBD applications. In this subsection we maintain a current list of links on the most important scientific studies on cannabinoids in medicine, which are broken down by group of diseases.

Rigorous clinical studies are still needed to evaluate the clinical potential of CBD for specific conditions. However, pre-clinical studies have shown CBD to have a wide range of effects and properties that may be therapeutically useful. These include, but are not limited to anti-seizure, antioxidant, neuroprotective, anti-inflammatory, analgesic, anti-tumor, anti-psychotic and anti-anxiety.

Currently 104 clinical trials around the world are being carried out. For further information on a specific study, visit directly the official webpage;


wolrd clinical trials.001 Just click on the disease  (alphabetical order) you are interested in:



Alzheimer’s disease

Anorexia & Cachexia

Anxiety and sleep disorders






  Colitis and Crohn’s

 Cardiovascular disorders



  Endocrine disorders




Huntington’s disease

Hyperactivity & attention disorders


Liver disorders

 Multiple sclerosis and epilepsy


 Neurodegenerative conditions



  Parkinson’s disease

Psychopathology and addiction

 Post-traumatic disorders

Sickle cell disease




Sources: PubMed – AmericanNewsReport – Time – ScienceDirect – AXS – University Of Connecticut – ScienceDaily – O’Schauhnessy’s –  Temple University School of Pharmacy in Philadelphia.

If you have any question feel free to contact us at any time at or just click here.

Pharmotech Team